Ori Ben-Yehuda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ori Ben-Yehuda has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Gregg Whitney Stone
Icahn School of Medicine at Mount Sinai , New York, NY
8 shared publications - Björn Redfors
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
6 shared publications - Akiko Maehara
Columbia University Irving Medical Center
5 shared publications - Patrick W. Serruys
University of Galway
5 shared publications - Revathy Sampath-Kumar
Division of Cardiovascular Medicine, University of California San Diego, La Jolla, California, USA
5 shared publications Ehtisham Mahmud
4 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Congestion Assessed With Inferior Vena Cava Ultrasound Predicts Long-Term Outcomes in Acute Decompensated Heart Failure
- 18 November 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (12)
Open AccessCongestion Assessed With Inferior Vena Cava Ultrasound Predicts Long-Term Outcomes in Acute Decompensated Heart Failure
- Open Access
- 12 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Seventy Seconds of Asystole
- 12 September 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (43)
Open AccessSeventy Seconds of Asystole
- 25 June 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (8)
Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy
BACKGROUND: Lipidomics, the comprehensive profiling of circulating lipid species, has emerged as a powerful tool to investigate metabolic alterations underlying coronary atherosclerosis. Understanding the mechanisms driving high-risk vulnerable plaque formation and progression to myocardial infarction remains a key therapeutic priority. This study investigates associations between circulating lipid metabolites and imaging-defined features of vulnerable coronary plaque. METHODS: Following revascularization, patients with myocardial infarction underwent 3-vessel coronary artery imaging with near-infrared spectroscopy and intravascular ultrasound to assess nonflow-limiting plaques for lipid core burden index and plaque burden. Multivariable models evaluated associations between 424 lipid metabolites in plasma, quantified by mass spectrometry, pan-coronary lipid, pan-coronary plaque burden, and high-risk vulnerable plaque measures (maximum lipid core burden index within any 4-mm segment across the entire lesion ≥324.7 and plaque burden ≥70%) in 877 patients. Findings were validated in the SCAPIS study (Swedish Cardiopulmonary Bioimage Study) using coronary computed tomography angiography–based measures of coronary artery calcium score and segment involvement score. RESULTS: We identified 156 significant associations ( P <0.05) between lipid metabolites and coronary plaque characteristics across 39 metabolic pathways. Sphingomyelins were inversely associated with all plaque metrics, and 1-palmitoyl-2-oleoyl-GPE (16:0/18:1), a phosphatidylethanolamine, was positively associated with all plaque metrics. After correcting for multiple testing, 27 lipid species across 7 pathways remained significant (q<0.05). The majority were linked to pan-coronary lipid burden, with the strongest inverse association observed for sphingomyelin d18:1/22:1, d18:2/22:0, and d16:1/24:1. Similar inverse patterns were seen for select dihydrosphingomyelins and fatty acid dicarboxylates. In contrast, 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) remained positively associated with pan-coronary lipid. In the SCAPIS validation cohort, 19 of the 27 significant lipid associations were successfully replicated (q<0.05). CONCLUSIONS: This study is the first to demonstrate that sphingomyelins are negatively and 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) positively associated with vulnerable coronary plaque features based on multimodality intracoronary imaging in patients with myocardial infarction. Moreover, these associations were validated in a large cohort using coronary computed tomography angiography–derived measures of plaque burden. These novel results may enable the development of new diagnostic and therapeutic strategies.
- 25 June 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (8)
Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy
BACKGROUND: Lipidomics, the comprehensive profiling of circulating lipid species, has emerged as a powerful tool to investigate metabolic alterations underlying coronary atherosclerosis. Understanding the mechanisms driving high-risk vulnerable plaque formation and progression to myocardial infarction remains a key therapeutic priority. This study investigates associations between circulating lipid metabolites and imaging-defined features of vulnerable coronary plaque. METHODS: Following revascularization, patients with myocardial infarction underwent 3-vessel coronary artery imaging with near-infrared spectroscopy and intravascular ultrasound to assess nonflow-limiting plaques for lipid core burden index and plaque burden. Multivariable models evaluated associations between 424 lipid metabolites in plasma, quantified by mass spectrometry, pan-coronary lipid, pan-coronary plaque burden, and high-risk vulnerable plaque measures (maximum lipid core burden index within any 4-mm segment across the entire lesion ≥324.7 and plaque burden ≥70%) in 877 patients. Findings were validated in the SCAPIS study (Swedish Cardiopulmonary Bioimage Study) using coronary computed tomography angiography–based measures of coronary artery calcium score and segment involvement score. RESULTS: We identified 156 significant associations ( P <0.05) between lipid metabolites and coronary plaque characteristics across 39 metabolic pathways. Sphingomyelins were inversely associated with all plaque metrics, and 1-palmitoyl-2-oleoyl-GPE (16:0/18:1), a phosphatidylethanolamine, was positively associated with all plaque metrics. After correcting for multiple testing, 27 lipid species across 7 pathways remained significant (q<0.05). The majority were linked to pan-coronary lipid burden, with the strongest inverse association observed for sphingomyelin d18:1/22:1, d18:2/22:0, and d16:1/24:1. Similar inverse patterns were seen for select dihydrosphingomyelins and fatty acid dicarboxylates. In contrast, 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) remained positively associated with pan-coronary lipid. In the SCAPIS validation cohort, 19 of the 27 significant lipid associations were successfully replicated (q<0.05). CONCLUSIONS: This study is the first to demonstrate that sphingomyelins are negatively and 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) positively associated with vulnerable coronary plaque features based on multimodality intracoronary imaging in patients with myocardial infarction. Moreover, these associations were validated in a large cohort using coronary computed tomography angiography–derived measures of plaque burden. These novel results may enable the development of new diagnostic and therapeutic strategies.
- Open Access
- 19 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102881
Left Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction
- 19 June 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (7) , 102881
Open AccessLeft Ventricular Ejection Fraction Trajectory and Long-Term Outcomes Following Percutaneous Coronary Intervention for Myocardial Infarction
- Open Access
- 6 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102724
Accelerating Testosterone Prescribing for U.S. Women
- 6 May 2026
- Published by Elsevier in JACC: Advances
- Vol. 5 (6) , 102724
Open AccessAccelerating Testosterone Prescribing for U.S. Women
- 24 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (12) , 890-901
Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial
BACKGROUND: Limited data are available regarding the relative rates, etiology, and long-term prognostic implications of spontaneous myocardial infarction (MI) after percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery for left main coronary artery disease (LMCAD). METHODS: MIs after PCI and CABG for LMCAD were adjudicated from the EXCEL trial (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization). Cox proportional hazards regression was performed to assess the association between spontaneous (and procedural) MI and cardiovascular and all-cause mortality at 5 years. RESULTS: Among 1882 patients who underwent LMCAD revascularization, spontaneous MI during 5-year follow-up occurred in 60 (6.8%) patients after PCI and in 29 (3.4%) patients after CABG (adjusted hazard ratio [adjHR], 2.01; 95 CI, 1.29–3.15; P =0.002). By multivariable analysis, spontaneous MI (as a time-adjusted covariate) was a strong independent predictor of subsequent cardiovascular mortality (adjHR, 9.39; 95% CI, 5.22–16.87) and all-cause mortality (adjHR, 4.77; 95% CI, 2.92–7.80) within 5 years, with consistent effects after PCI and CABG ( P interaction =0.60 and 0.78, respectively). In the same models, procedural MI as defined by extensive myonecrosis was associated with 5-year cardiovascular (adjHR, 3.02; 95% CI, 1.64–5.56) and all-cause mortality (adjHR, 2.38; 95% CI, 1.48–3.80), with consistent effects after PCI and CABG ( P interaction =0.23 and 0.34, respectively). CONCLUSIONS: In the EXCEL trial, spontaneous MI occurred relatively infrequently within 5 years after LMCAD revascularization but at a higher rate after PCI compared with CABG. Spontaneous MI after revascularization was strongly related to subsequent cardiovascular and all-cause mortality, consistently after PCI and CABG, and was more strongly associated with mortality than was large procedural MI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT01205776
- 24 March 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (12) , 890-901
Spontaneous Myocardial Infarction After Left Main Revascularization: The EXCEL Trial
BACKGROUND: Limited data are available regarding the relative rates, etiology, and long-term prognostic implications of spontaneous myocardial infarction (MI) after percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery for left main coronary artery disease (LMCAD). METHODS: MIs after PCI and CABG for LMCAD were adjudicated from the EXCEL trial (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization). Cox proportional hazards regression was performed to assess the association between spontaneous (and procedural) MI and cardiovascular and all-cause mortality at 5 years. RESULTS: Among 1882 patients who underwent LMCAD revascularization, spontaneous MI during 5-year follow-up occurred in 60 (6.8%) patients after PCI and in 29 (3.4%) patients after CABG (adjusted hazard ratio [adjHR], 2.01; 95 CI, 1.29–3.15; P =0.002). By multivariable analysis, spontaneous MI (as a time-adjusted covariate) was a strong independent predictor of subsequent cardiovascular mortality (adjHR, 9.39; 95% CI, 5.22–16.87) and all-cause mortality (adjHR, 4.77; 95% CI, 2.92–7.80) within 5 years, with consistent effects after PCI and CABG ( P interaction =0.60 and 0.78, respectively). In the same models, procedural MI as defined by extensive myonecrosis was associated with 5-year cardiovascular (adjHR, 3.02; 95% CI, 1.64–5.56) and all-cause mortality (adjHR, 2.38; 95% CI, 1.48–3.80), with consistent effects after PCI and CABG ( P interaction =0.23 and 0.34, respectively). CONCLUSIONS: In the EXCEL trial, spontaneous MI occurred relatively infrequently within 5 years after LMCAD revascularization but at a higher rate after PCI compared with CABG. Spontaneous MI after revascularization was strongly related to subsequent cardiovascular and all-cause mortality, consistently after PCI and CABG, and was more strongly associated with mortality than was large procedural MI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT01205776
- Open Access
- 26 April 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (5) , 101723
Impact of Hispanic Ethnicity, Geography, and Insurance Status on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
- 26 April 2025
- Published by Elsevier in JACC: Advances
- Vol. 4 (5) , 101723
Open AccessImpact of Hispanic Ethnicity, Geography, and Insurance Status on Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
- 10 April 2025
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 392 (14) , 1443-1444
Aortic Stenosis — When Valve Intervention Is Not Enough
- 10 April 2025
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 392 (14) , 1443-1444
Aortic Stenosis — When Valve Intervention Is Not Enough
- Open Access
- 21 January 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (1) , 102450
Patient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover
- 21 January 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (1) , 102450
Open AccessPatient Characteristics and Outcomes of Radial to Femoral Access-Site Crossover